Being able to repair existing damage in Multiple Sclerosis is the next major step in treatment advances. Remyelination is an exciting and important area of MS research. We were lucky enough to have Dr Travis Stiles (CEO, Novoron Bioscience) travel from California, USA to our Research Day, where he talked about his work in this field.
Travis discussed the background to Novoron’s research and the results they have seen so far for their novel treatment for myelin repair. As well as this, Travis provided a valuable insight into the process behind the development of new drugs and the role that the MS community can play in this. Here is the full 32 minute presentation by Dr Travis Stiles.